Akshay Vaishnaw

Companies

• Hemab Therapeutics Holdings, Inc.Board member Apr 30, 2026 to now¹
• Scholar Rock Holding CorpPresident Apr 29, 2025 to now²
• Scholar Rock Holding CorpBoard member May 23, 2019 to now³
• Editas MedicineBoard member Jul 29, 2016 to Jun 3, 2024⁴
• Alnylam PharmaceuticalsPresident Mar 16, 2018 to Aug 7, 2023⁵
• Alnylam PharmaceuticalsSVP, Clinical Research Mar 13, 2009 to Mar 5, 2018⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SRScholar Rock Holding Corp SRRK630,542 shares⁷$25.7M at $40.78Apr 16, 2026
• Alnylam Pharmaceuticals ALNY23,289 shares⁸$5.5M at $235.58Aug 7, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 16, 2026Sold 12,246 shares at $49.57 of Scholar Rock Holding Corp⁷
• Feb 9, 2026Granted 47,021 shares of Scholar Rock Holding Corp⁹
• Jan 13, 2026Sold 20,438 shares at $42.70 of Scholar Rock Holding Corp¹⁰
• May 29, 2025Sold 1,620 shares at $30.01 of Scholar Rock Holding Corp¹¹
• May 29, 2025Sold 5,130 shares at $29.63 of Scholar Rock Holding Corp¹¹
• Apr 27, 2025Granted 500,000 shares of Scholar Rock Holding Corp¹²
• Apr 27, 2025Granted 100,000 shares of Scholar Rock Holding Corp¹²
• Jun 27, 2024Granted 13,500 shares of Scholar Rock Holding Corp¹³
• Aug 4, 2023Sold 192 shares at $189.31 of Alnylam Pharmaceuticals⁸
• Aug 4, 2023Sold 17 shares at $188.40 of Alnylam Pharmaceuticals⁸
• Aug 4, 2023Sold 101 shares at $187.37 of Alnylam Pharmaceuticals⁸
• Aug 4, 2023Sold 1,107 shares at $186.39 of Alnylam Pharmaceuticals⁸
• Aug 4, 2023Sold 1,869 shares at $185.54 of Alnylam Pharmaceuticals⁸
• Aug 4, 2023Sold 771 shares at $184.70 of Alnylam Pharmaceuticals⁸
• Aug 3, 2023Granted 3,859 shares of Alnylam Pharmaceuticals⁸
• Aug 3, 2023Granted 5,082 shares of Alnylam Pharmaceuticals⁸
• Apr 27, 2023Sold 168 shares at $197.08 of Alnylam Pharmaceuticals¹⁴
• Apr 27, 2023Sold 104 shares at $195.65 of Alnylam Pharmaceuticals¹⁴
• Apr 27, 2023Sold 1,013 shares at $194.94 of Alnylam Pharmaceuticals¹⁴
• Apr 27, 2023Sold 910 shares at $193.93 of Alnylam Pharmaceuticals¹⁴
• Apr 27, 2023Sold 197 shares at $193.18 of Alnylam Pharmaceuticals¹⁴
• Apr 26, 2023Granted 5,312 shares of Alnylam Pharmaceuticals¹⁴
• Feb 10, 2023Sold 4,302 shares at $217.05 of Alnylam Pharmaceuticals¹⁵
• Feb 10, 2023Sold 19,447 shares at $216.38 of Alnylam Pharmaceuticals¹⁵
• Feb 10, 2023Sold 10,279 shares at $215.59 of Alnylam Pharmaceuticals¹⁵